AUCATZYL Q Code: Q2058
Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
Q4 2026 Medicare Payment Limit for Q2058, effective October 1, 2026: $293,725.702 per HCPCS billing unit. CMS publishes none for Q3 2026. From CMS's final file.
Drug & Product Overview
About AUCATZYL
Aucatzyl is a medication aligned to the HCPCS Q Code: Q2058 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Autolus.
Manufacturers, reach out to us to add more information.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 83047-0410-04 | Aucatzyl | Autolus Inc. | 2 | Kit |
AUCATZYL Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →AUCATZYL CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug |
| 96415 | Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
AUCATZYL Medically Unlikely Edits (MUE)
The most billing units of Q2058 Medicare will pay for one patient in one day, as published by CMS. 1 unit = per therapeutic dose.
MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →
AUCATZYL Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available AUCATZYL billing and coding guide?
Are there any available AUCATZYL patient assistance programs?
Where can I find AUCATZYL prescribing information?
Where can I find AUCATZYL side effect information?
Does billing AUCATZYL require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to AUCATZYL.